RespireRx Pharmaceuticals Inc (RSPI)

[myostrain]

Statistics and data analysis on microbiotechs is not always that reliable in periods of meaningfull information. The current 60DMA, is the lull period after the drop in sp/high volume, where the volume was realisticly below average; The change from 45cents can be in association to shareholder buys, recent events from SP and associated progressive positive views on ampakines and maybe a little setting up or nibbling by daily Joe's and maybe the big-uns.
The volume was higher in the run up to 80cents, a good 300% off the 60DMA.

Stating "the mo mo boys are still not here" and "setting up" both seem to be relative valid statements